Section I
1 – 10 of 4971
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Dynamic methylation and expression of alternative promoters for oestrogen receptor alpha in cell line models of fulvestrant resistance
- Contribution to journal › Article
-
Mark
Statin Therapy in Early Breast Cancer : The MASTER Trial; A Randomized Phase III, Placebo-Controlled Comparison of Standard (Neo)Adjuvant Therapy Plus Atorvastatin versus Standard (Neo)Adjuvant Therapy Plus Placebo
- Contribution to journal › Article
-
Mark
Validation of data quality in the Swedish quality register of gynecologic cancer for cervical cancer and vulvar cancer—a Swedish gynecologic cancer group (Swe-GCG) study
- Contribution to journal › Article
-
Mark
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC : Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial
- Contribution to journal › Article
-
Mark
Aspects of Host-Tumor Interactions and Outcome: Focus on Breast Cancer and Head and Neck Cancer
(2025) In Lund University, Faculty of Medicine Doctoral Dissertation Series
- Thesis › Doctoral thesis (compilation)
-
Mark
FEASIBILITY AND POTENTIAL BENEFITS OF MODERATE INTENSITY CYCLING IN PEOPLE LIVING WITH LOWER LIMB LYMPHEDEMA : A PILOT RANDOMIZED CONTROLLED TRIAL
- Contribution to journal › Article
-
Mark
Polygenic scores in Familial breast cancer cases with and without pathogenic variants and the risk of contralateral breast cancer
- Contribution to journal › Article
-
Mark
Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferation
- Contribution to journal › Article
-
Mark
Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic cancer
- Contribution to journal › Article
-
Mark
Serine-arginine protein kinase 1 (SRPK1) is under-expressed in mucinous colorectal cancer, and may mediate resistance to oxaliplatin
- Contribution to journal › Article
